Loading...
XSHE300485
Market cap444mUSD
Jan 09, Last price  
6.77CNY
1D
-0.73%
1Q
-8.88%
Jan 2017
-68.39%
IPO
-55.55%
Name

Beijing Science Sun Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:300485 chart
P/E
31.68
P/S
6.84
EPS
0.21
Div Yield, %
1.27%
Shrs. gr., 5y
0.42%
Rev. gr., 5y
-19.70%
Revenues
477m
-35.12%
245,023,222396,012,790480,212,178589,846,385607,138,310616,238,487749,986,8481,427,750,9431,190,902,5061,094,225,2801,050,805,089734,546,852476,569,581
Net income
103m
-49.73%
84,659,947132,566,730160,788,855202,571,532209,273,984258,405,896281,604,133283,107,048148,639,043154,903,454402,270,478204,734,954102,917,838
CFO
21m
-80.79%
0151,933,363196,824,109214,225,147169,357,075212,893,474108,212,673146,516,272172,523,039263,725,621183,295,288110,434,54321,210,976
Dividend
May 29, 20240.022 CNY/sh
Earnings
Apr 30, 2025

Profile

Beijing Science Sun Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of injections in China. It offers products for cardiovascular, cerebrovascular, immunomodulatory, nervous systems, and other areas. The company was founded in 1999 and is headquartered in Beijing, China.
URL
https://www.ssyy.com.cn/
IPO date
Jun 26, 2015
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
476,570
-35.12%
734,547
-30.10%
Cost of revenue
470,123
657,403
Unusual Expense (Income)
NOPBT
6,447
77,144
NOPBT Margin
1.35%
10.50%
Operating Taxes
25,755
51,966
Tax Rate
399.50%
67.36%
NOPAT
(19,308)
25,179
Net income
102,918
-49.73%
204,735
-49.11%
Dividends
(41,396)
(80,878)
Dividend yield
0.80%
1.40%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
(9,123)
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
(1,554,881)
(1,634,624)
Cash flow
Cash from operating activities
21,211
110,435
CAPEX
(52,913)
Cash from investing activities
32,391
Cash from financing activities
FCF
4,390
70,143
Balance
Cash
1,173,580
1,121,597
Long term investments
381,301
503,904
Excess cash
1,531,053
1,588,774
Stockholders' equity
2,376,981
2,583,791
Invested Capital
1,936,539
1,810,820
ROIC
1.31%
ROCE
0.18%
2.22%
EV
Common stock shares outstanding
490,085
481,666
Price
10.59
-11.60%
11.98
-9.17%
Market cap
5,190,000
-10.06%
5,770,363
-9.17%
EV
3,666,695
4,173,826
EBITDA
55,185
124,743
EV/EBITDA
66.44
33.46
Interest
55
34
Interest/NOPBT
0.86%
0.04%